Ibu-Lysin

Ibuprofen, the active ingredient in Ibu-Lysin, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats pain, fever and inflammation in adults and children when appropriate.

GNH USA supplies Ibu-Lysin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen acts on prostaglandin pathways to relieve common discomforts and inflammatory conditions. - Pain: provides analgesic relief for mild to moderate aches such as headache, dental pain or musculoskeletal strain. - Fever: lowers elevated body temperature associated with infections or inflammatory processes. - Inflammatory conditions: reduces swelling and discomfort in arthritis, bursitis or other localized inflammations.

Adverse reactions may occur with ibuprofen use.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia or abdominal discomfort. - Headache: mild to moderate tension‑type headache. - Dizziness: transient feeling of light‑headedness. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration: may present as black stools or vomiting blood. - Renal impairment: reduced kidney function, especially in dehydrated patients. - Severe hypersensitivity: anaphylaxis, angioedema or Stevens‑Johnson syndrome.

Before using ibuprofen, consider the following safety measures. - Assess renal function: avoid use in patients with severe kidney disease. - Evaluate cardiovascular risk: use cautiously in individuals with hypertension or heart disease. - Review gastrointestinal history: avoid in those with active ulcers or bleeding disorders. - Monitor for asthma exacerbation: ibuprofen can trigger bronchospasm in susceptible patients. - Avoid concurrent NSAIDs: do not combine with other non‑steroidal anti‑inflammatory drugs. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Ibuprofen may interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - High‑dose aspirin: heightened gastrointestinal toxicity. - Selective COX‑2 inhibitors: additive renal and cardiovascular effects.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in antihypertensive efficacy and renal function. - Lithium: ibuprofen can raise serum lithium levels, risking toxicity. - Methotrexate: decreased clearance may enhance methotrexate toxicity.